Perceptive Advisors »

Palvella Therapeutics Inc Ne shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $25M 395k 62.69

More positions owned by Perceptive Advisors

Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Celcuity (CELC)
Nuvalent Inc-a (NUVL)
Merus N V (MRUS)
Amylyx Pharmaceuticals (AMLX)
Roivant Sciences SHS (ROIV)
Meiragtx Holdings (MGTX)
Insmed Com Par $.01 (INSM)
Travere Therapeutics (TVTX)
CryoLife (AORT)
Praxis Precision Medicines I Com New (PRAX)
Immatics SHS (IMTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Perceptive Advisors

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
Perceptive Advisors
Woodline Partners
Federated Investors
Point72 Asset Management
Nantahala Capital Management
Goldman Sachs Group
Samsara BioCapital
Fred Alger Management
Geode Capital Management

View all funds holding Palvella Therapeutics Inc Ne